Showing results (1221-1230 of 6,669) with videos related to
Sort By:
Pageof 667
Annals of Hematology|October 18, 2012
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overloadF Nolte, B Höchsmann, A Giagounidis, et al.Annals of Hematology|October 16, 2012
Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosomeDayane B Koshiyama, Marcelo E Z Capra, Giorgio A Paskulin, et al.Annals of Hematology|October 12, 2012
Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosisBurçin Tezcanlı Kaymaz, Nur Selvi, Cumhur Gündüz, et al.Annals of Hematology|October 12, 2012
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemiaMario Tiribelli, Roberto Latagliata, Luigiana Luciano, et al.Annals of Hematology|October 17, 2012
Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patientsIrene Luna, Esperanza Such, Jose Cervera, et al.Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.Annals of Hematology|March 24, 2010
Evaluating bleeding severity in immune thrombocytopenia (ITP)Cindy E NeunertAnnals of Hematology|March 24, 2010
Genetic studies in pediatric ITP: outlook, feasibility, and requirementsAnke K Bergmann, Rachael F Grace, Ellis J NeufeldAnnals of Hematology|May 12, 2023
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphomaGrzegorz S Nowakowski, Dok Hyun Yoon, Patrizia Mondello, et al.Annals of Hematology|May 16, 2023
Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective studyLi-Qiang Wu, Li-Fang Huang, Hui Yang, et al.Pageof 667